CME Group (CME) Expected to Announce Quarterly Sales of $1.12 Billion

Wall Street analysts expect CME Group (NASDAQ:CME) to announce $1.12 billion in sales for the current fiscal quarter, Zacks Investment Research reports. Three analysts have issued estimates for CME Group’s earnings. The lowest sales estimate is $1.12 billion and the highest is $1.13 billion. CME Group reported sales of $929.30 million in the same quarter last year, which would suggest a positive year over year growth rate of 20.5%. The business is scheduled to issue its next earnings results before the market opens on Thursday, April 26th.

According to Zacks, analysts expect that CME Group will report full year sales of $4.17 billion for the current financial year, with estimates ranging from $4.07 billion to $4.31 billion. For the next year, analysts expect that the company will post sales of $4.29 billion per share, with estimates ranging from $4.21 billion to $4.38 billion. Zacks Investment Research’s sales calculations are a mean average based on a survey of sell-side research analysts that follow CME Group.

How to Become a New Pot Stock Millionaire

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.10 by $0.02. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The business had revenue of $900.00 million for the quarter, compared to analysts’ expectations of $886.85 million. During the same quarter in the previous year, the firm earned $1.14 earnings per share. The business’s revenue was down 1.4% on a year-over-year basis.



A number of brokerages have recently commented on CME. Sanford C. Bernstein began coverage on CME Group in a research report on Monday, April 9th. They set an “outperform” rating and a $190.00 price target on the stock. Deutsche Bank upped their price target on CME Group from $185.00 to $197.00 and gave the company a “buy” rating in a research report on Friday, April 6th. Zacks Investment Research raised CME Group from a “hold” rating to a “buy” rating and set a $180.00 price target on the stock in a research report on Friday, April 6th. ValuEngine raised CME Group from a “hold” rating to a “buy” rating in a research report on Monday, April 2nd. Finally, BidaskClub raised CME Group from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, March 27th. Three analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. CME Group has an average rating of “Buy” and an average price target of $165.57.

CME stock traded up $0.61 during midday trading on Friday, hitting $165.08. The company’s stock had a trading volume of 1,589,375 shares, compared to its average volume of 1,743,985. The company has a current ratio of 1.03, a quick ratio of 1.03 and a debt-to-equity ratio of 0.10. CME Group has a 1 year low of $114.82 and a 1 year high of $171.71. The stock has a market cap of $56,231.60, a P/E ratio of 34.61, a P/E/G ratio of 2.29 and a beta of 0.56.

The business also recently disclosed a quarterly dividend, which was paid on Monday, March 26th. Investors of record on Friday, March 9th were paid a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.70%. This is a positive change from CME Group’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend was Thursday, March 8th. CME Group’s payout ratio is presently 58.70%.

In related news, Director Ronald A. Pankau sold 200 shares of the business’s stock in a transaction on Wednesday, February 14th. The stock was sold at an average price of $159.91, for a total transaction of $31,982.00. Following the sale, the director now directly owns 3,809 shares in the company, valued at approximately $609,097.19. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Chairman Terrence A. Duffy sold 20,000 shares of the business’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the sale, the chairman now owns 99,239 shares in the company, valued at $15,050,586.74. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 35,699 shares of company stock worth $5,532,362. 0.57% of the stock is currently owned by corporate insiders.

Several large investors have recently added to or reduced their stakes in the stock. Ontario Teachers Pension Plan Board increased its stake in CME Group by 12.4% in the 4th quarter. Ontario Teachers Pension Plan Board now owns 81,393 shares of the financial services provider’s stock worth $11,887,000 after acquiring an additional 8,991 shares during the last quarter. Honeywell International Inc. bought a new position in CME Group in the 4th quarter worth about $35,052,000. Capital Advisors Inc. OK increased its stake in CME Group by 5.5% in the 4th quarter. Capital Advisors Inc. OK now owns 88,822 shares of the financial services provider’s stock worth $12,972,000 after acquiring an additional 4,592 shares during the last quarter. Viking Fund Management LLC increased its stake in CME Group by 4.3% in the 4th quarter. Viking Fund Management LLC now owns 29,200 shares of the financial services provider’s stock worth $4,265,000 after acquiring an additional 1,200 shares during the last quarter. Finally, LPL Financial LLC increased its stake in CME Group by 9.0% in the 4th quarter. LPL Financial LLC now owns 22,193 shares of the financial services provider’s stock worth $3,241,000 after acquiring an additional 1,841 shares during the last quarter. Institutional investors own 83.41% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: “CME Group (CME) Expected to Announce Quarterly Sales of $1.12 Billion” was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are reading this news story on another domain, it was copied illegally and republished in violation of U.S. & international copyright & trademark law. The original version of this news story can be read at https://stocknewstimes.com/2018/04/20/cme-group-cme-expected-to-announce-quarterly-sales-of-1-12-billion.html.

About CME Group

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Get a free copy of the Zacks research report on CME Group (CME)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply